Rybelsus 14 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FDC1D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,742
Award facts
- Contract value 100% obligated
- $17,741.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,741.80 to AmerisourceBergen Drug Corp for the supply of Rybelsus 14 mg tablets (30-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 29, 2026, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to serve as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's demonstrated capability to fulfill government contracts for essential pharmaceuticals is reflected in its extensive portfolio of medical product deliveries across multiple therapeutic domains, including diabetes medications, neurological treatments, and specialized medical supplies. As a non-set-aside award, this delivery order was competitively procured, underscoring the contractor's ability to meet federal procurement requirements through open competition alongside other qualified vendors in the pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FDC1D?
SPE2DR26FDC1D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FDC1D worth?
The government has obligated $17,742 on SPE2DR26FDC1D.
Is contract SPE2DR26FDC1D an order under another contract?
Yes. SPE2DR26FDC1D is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDC1D competed?
The extent of competition for SPE2DR26FDC1D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award